Literature DB >> 15856295

The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance.

In Kyoung Choi1, Duk Hee Kim, Ho-Seong Kim.   

Abstract

UNLABELLED: An oral glucose tolerance test (OGTT) was performed in 103 patients with Turner syndrome (TS) who had normal fasting and postprandial glucose levels. The plasma glucose, insulin, C-peptide and proinsulin levels were measured every 30 min during the test. Using a homeostatic model assessment (HOMA) and a quantitative insulin sensitivity check index (QUICKI), the insulin resistance in TS patients was investigated. Diabetes mellitus and impaired glucose tolerance (IGT) were newly diagnosed in two and 18 patients respectively. There was a significant increase in mean plasma glucose, insulin, C-peptide and proinsulin response during an OGTT in the IGT group in contrast to the normal glucose tolerance (NGT) group ( P < 0.05). There was a significant decrease in the quantitative insulin sensitivity check index (QUICKI) in the IGT group in contrast to the NGT group ( P < 0.05). The fasting insulin and triglyceride levels strongly predicted the 2 h glucose level during the OGTT ( P < 0.05).
CONCLUSION: The oral glucose tolerance test is superior to the fasting and postprandial plasma glucose test for the early detection of abnormalities of carbohydrate metabolism in patients with Turner syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856295     DOI: 10.1007/s00431-005-1643-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.

Authors:  Yvonne K Van Pareren; Sabine M P F De Muinck Keizer-Schrama; Theo Stijnen; Theo C J Sas; Stenvert L S Drop
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols.

Authors:  M F Saad; G M Steil; W W Kades; M F Ayad; W A Elsewafy; R Boyadjian; S D Jinagouda; R N Bergman
Journal:  Diabetes       Date:  1997-07       Impact factor: 9.461

3.  Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.

Authors:  G Nijpels; C Popp-Snijders; P J Kostense; L M Bouter; R J Heine
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 4.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

5.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention.

Authors:  Jirí Hrebícek; Vladimír Janout; Jana Malincíková; Dagmar Horáková; Ludek Cízek
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Treatment of Turner's syndrome with recombinant human growth hormone (somatrem).

Authors:  B Lippe; R G Rosenfeld; R L Hintz; A J Johanson; J Frane; B Sherman
Journal:  Acta Paediatr Scand Suppl       Date:  1988

Review 7.  The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

Authors:  J E Gerich
Journal:  Endocr Rev       Date:  1998-08       Impact factor: 19.871

8.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

Authors:  R N Bergman; R Prager; A Volund; J M Olefsky
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.

Authors:  S N Davis; L Monti; P M Piatti; N Moller; L Ng; S Coppack; M May; M D Brown; H Orskov; K G Alberti
Journal:  Diabetes Res       Date:  1993

Review 10.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach.

Authors:  R N Bergman
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

View more
  3 in total

1.  X-chromosome gene dosage and the risk of diabetes in Turner syndrome.

Authors:  Vladimir K Bakalov; Clara Cheng; Jian Zhou; Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

2.  Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome.

Authors:  Nicole Sheanon; Deborah Elder; Jane Khoury; Lori Casnellie; Iris Gutmark-Little; Joseph Cernich; Phillipe F Backeljauw
Journal:  Horm Res Paediatr       Date:  2021-10-15       Impact factor: 4.275

3.  Insulin Sensitivity and Pancreatic β-Cell Function in Ecuadorian Women With Turner Syndrome.

Authors:  Francisco Álvarez-Nava; Daniela Bastidas; Marcia Racines-Orbe; Jéssica Guarderas
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.